Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Mucosal Immunol ; 9(2): 364-78, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26220165

ABSTRACT

Recent evidence has revealed an unsuspected suppressive role played by neutrophils during microbial infections. An especially intriguing aspect of this role is the ability of neutrophils to produce interleukin (IL)-10 following interaction with lipopolysaccharide (LPS)-stimulated regulatory T (Treg) cells. The present study demonstrates that generation of IL-10 in neutrophils induced by LPS-stimulated Treg cells required direct cell-cell contact. This effect was dependent on the binding of CD11b and intercellular adhesion molecule 1. Neither stimulation of neutrophils with LPS nor their culture with unstimulated Treg cells, CD3/CD28 monoclonal antibodies-stimulated Treg cells, or T conventional cells affected intracellular IL-10 expression. IL-10-positive neutrophils were also induced by exogenous IL-10, providing an example of a positive feedback loop. Both LPS-stimulated Treg cells and exogenous IL-10 exclusively promoted posttranslational modifications of histones, H3K4me3 and H3Ac Lys4, that activate IL-10 genomic locus in neutrophils, while the promoter of IL-10 gene was inactive in resting, LPS-stimulated neutrophils, following blocking of direct interaction with LPS-stimulated Treg cells or in LPS-preactivated neutrophils incubated with LPS-stimulated Treg cells. We additionally confirmed the presence of IL-10-producing neutrophils in vivo in patients with periodontal abscess induced by Gram-negative bacteria, as opposed to neutrophils isolated from the site of aseptic inflammation in patients with neuromyelitis optica.


Subject(s)
Cell Communication/immunology , Interleukin-10/immunology , Neutrophils/immunology , Protein Processing, Post-Translational , T-Lymphocytes, Regulatory/immunology , Antibodies, Monoclonal/pharmacology , Binding Sites , CD11b Antigen/genetics , CD11b Antigen/immunology , CD28 Antigens/genetics , CD28 Antigens/immunology , CD3 Complex/genetics , CD3 Complex/immunology , Coculture Techniques , Feedback, Physiological , Histones/genetics , Histones/immunology , Humans , Intercellular Adhesion Molecule-1/genetics , Intercellular Adhesion Molecule-1/immunology , Interleukin-10/genetics , Interleukin-10/pharmacology , Lipopolysaccharides/pharmacology , Lymphocyte Activation , Neuromyelitis Optica/genetics , Neuromyelitis Optica/immunology , Neuromyelitis Optica/pathology , Neutrophils/pathology , Periodontal Abscess/genetics , Periodontal Abscess/immunology , Periodontal Abscess/pathology , Primary Cell Culture , Promoter Regions, Genetic , Protein Binding , Signal Transduction , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/pathology
2.
Curr Top Microbiol Immunol ; 314: 195-212, 2007.
Article in English | MEDLINE | ID: mdl-17593662

ABSTRACT

Valpha14 invariant natural killer T (Valpha14i NKT) cells are a unique lineage of mouse T cells that share properties with both NK cells and memory T cells. Valpha14i NKT cells recognize CDld-associated glycolipids via a semi-invariant T cell receptor (TCR) composed of an invariant Valpha14-Jalpha 18 chain paired preferentially with a restricted set of TCRbeta chains. During development in the thymus, rare CD4+ CD8+ (DP) cortical thymocytes that successfully rearrange the semi-invariant TCR are directed to the Valpha14i NKT cell lineage via interactions with CD d-associated endogenous glycolipids expressed by other DP thymocytes. As they mature, Valphal4i NKT lineage cells upregulate activation markers such as CD44 and subsequently express NK-related molecules such as NKI.1 and members of the Ly-49 inhibitory receptor family. The developmental program of Valpha l4i NKT cells is critically regulated by a number of signaling cues that have little or no effect on conventional T cell development, such as the Fyn/SAP/SLAM pathway, NFkappaB and T-bet transcription factors, and the cytokine IL-15. The unique developmental requirements of Valphal4i NKT cells may represent a paradigm for other unconventional T cell subsets that are positively selected by agonist ligands expressed on hematopoietic cells.


Subject(s)
Cell Differentiation , Killer Cells, Natural , Animals , Cell Differentiation/genetics , Cell Differentiation/immunology , Cell Differentiation/physiology , Humans , Killer Cells, Natural/cytology , Killer Cells, Natural/immunology , Killer Cells, Natural/physiology , Mice , Signal Transduction , T-Lymphocyte Subsets/cytology , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/physiology
3.
Neurology ; 64(7): 1144-51, 2005 Apr 12.
Article in English | MEDLINE | ID: mdl-15824338

ABSTRACT

BACKGROUND: There is no consensus method for determining progression of disability in patients with multiple sclerosis (MS) when each patient has had only a single assessment in the course of the disease. METHODS: Using data from two large longitudinal databases, the authors tested whether cross-sectional disability assessments are representative of disease severity as a whole. An algorithm, the Multiple Sclerosis Severity Score (MSSS), which relates scores on the Expanded Disability Status Scale (EDSS) to the distribution of disability in patients with comparable disease durations, was devised and then applied to a collection of 9,892 patients from 11 countries to create the Global MSSS. In order to compare different methods of detecting such effects the authors simulated the effects of a genetic factor on disability. RESULTS: Cross-sectional EDSS measurements made after the first year were representative of overall disease severity. The MSSS was more powerful than the other methods the authors tested for detecting different rates of disease progression. CONCLUSION: The Multiple Sclerosis Severity Score (MSSS) is a powerful method for comparing disease progression using single assessment data. The Global MSSS can be used as a reference table for future disability comparisons. While useful for comparing groups of patients, disease fluctuation precludes its use as a predictor of future disability in an individual.


Subject(s)
Disability Evaluation , Multiple Sclerosis/diagnosis , Severity of Illness Index , Adult , Age of Onset , Cohort Studies , Cross-Sectional Studies , Databases, Factual , Disease Progression , Female , France/epidemiology , Humans , Longitudinal Studies , Male , Middle Aged , Models, Neurological , Models, Statistical , Multiple Sclerosis/epidemiology , Multiple Sclerosis/physiopathology , Predictive Value of Tests , Prognosis , Recurrence , Reproducibility of Results
4.
Ann Neurol ; 44(1): 70-5, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9667594

ABSTRACT

Intracellular adhesion molecule-1 (ICAM-1) plays an important role in the cascade of adhesion events in the homing of inflammatory cells to the central nervous system (CNS) in experimental autoimmune encephalomyelitis (EAE) and in multiple sclerosis (MS). Two single-base ICAM-1 polymorphisms have been described, in exons 4 and 6, changing codons 241 and 469 in the ICAM-1 gene, respectively. Both polymorphisms result in amino acid changes and can potentially lead to different interactions of ICAM-1 with its ligands. To detect ICAM-1 gene polymorphisms in MS, we have developed a highly sensitive and site-specific, two-stage, nested polymerase chain reaction. Genomic DNA was extracted from blood cells of 79 MS patients and 68 control subjects. The results were confirmed by direct dideoxy chain termination sequencing. The frequency of exon 6 allele T was found to be significantly higher in MS patients than in controls (68% vs 49%). Most interesting, the frequency of exon 6 homozygote K469 was significantly higher in MS patients than in controls (53% vs 34%). Higher frequency of the K469 genotype was found to be independent of possible linkage with the previously described MS susceptibility factor, the HLA class II DR2 allele. In the present study, we have shown for the first time the ICAM-1 gene polymorphisms in MS. The results indicate increased frequency of ICAM-1 exon 6 allele T in MS patients, which may contribute to the MS genetics background.


Subject(s)
Intercellular Adhesion Molecule-1/genetics , Multiple Sclerosis/genetics , Point Mutation , Base Sequence , Case-Control Studies , Chi-Square Distribution , DNA/analysis , Gene Frequency , Genetic Linkage , Genetic Testing , Genotype , Humans , Magnetic Resonance Imaging , Multiple Sclerosis/diagnosis , Polymorphism, Genetic , Random Allocation , Reference Values , White People/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...